CAI
Caris Life Sciences, Inc. Common Stock
NASDAQ: CAI · HEALTHCARE · BIOTECHNOLOGY
$17.77
-3.63% today
Updated 2026-04-29
Market cap
$5.02B
P/E ratio
—
P/S ratio
6.19x
EPS (TTM)
$-3.22
Dividend yield
—
52W range
$16 – $43
Volume
2.3M
WallStSmart proprietary scores
41
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A6.0
Quality
B5.0
Profitability
C+4.0
Valuation
C4/9
Piotroski F-Score
Moderate
-7.6
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$29.69
+67.08%
12-Month target
—
—
Intrinsic (DCF)
$12.32
Margin of safety
-74.51%
1 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $29.29M — positive
+ Revenue growth 125.40% QoQ
Risks
- Altman Z -7.64 — distress zone
- Thin margins at -8.39%
- 74.51% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $258.49M | $306.13M | $412.26M | $812.03M | $812.03M |
| Net income | $-320.83M | $-341.42M | $-281.89M | $-537.96M | $81.96M |
| EPS | — | — | — | — | $-3.22 |
| Free cash flow | $-327.96M | $-298.42M | $-253.64M | $66.89M | $29.29M |
| Profit margin | -124.12% | -111.53% | -68.38% | -66.25% | -8.39% |
Peer comparison
Smart narrative
Caris Life Sciences, Inc. Common Stock trades at $17.77. Our Smart Value Score of 41/100 indicates the stock is fair. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -7.64, it sits in the distress. TTM revenue stands at $812.03M. with profit margins at -8.39%. Our DCF model estimates intrinsic value at $12.32.
Frequently asked questions
What is Caris Life Sciences, Inc. Common Stock's stock price?
Caris Life Sciences, Inc. Common Stock (CAI) trades at $17.77.
Is Caris Life Sciences, Inc. Common Stock overvalued?
Smart Value Score 41/100 (Grade D, Sell). DCF value $12.32.
What is the price target of Caris Life Sciences, Inc. Common Stock (CAI)?
The analyst target price is $29.69, representing +67.1% upside from the current price of $17.77.
What is the intrinsic value of Caris Life Sciences, Inc. Common Stock (CAI)?
Based on our DCF model, intrinsic value is $12.32, a -74.5% margin of safety versus $17.77.
What is Caris Life Sciences, Inc. Common Stock's revenue?
TTM revenue is $812.03M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-7.64 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio6.19x
ROE-45.40%
Beta—
50D MA$19.17
200D MA$26.65
Shares out0.28B
Float0.10B
Short ratio—
Avg volume2.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—